Abstract
Xanthine oxidase (XO) is a critical source of reactive oxygen species (ROS) in inflammatory disease. Focus, however, has centered almost exclusively on XO-derived superoxide (O2•−) while direct H2O2 production from XO has been less well-investigated. Therefore, we examined the relative quantities of O2•− and H2O2 produced by XO under a range (1–21%) of O2 tensions. At O2 concentrations between 10 and 21 %, H2O2 accounted for ~ 75% of ROS production. As O2 concentrations were lowered, there was a concentration-dependent increase in H2O2 formation, accounting for 90% of ROS production at 1% O2. Alterations in pH between 5.5 and 7.4 did not affect the relative proportions of H2O2 and O2•− formation. Immobilization of XO, by binding to heparin-Sepharose, further enhanced relative H2O2 production by ~30%, under both normoxic and hypoxic conditions. Furthermore, XO bound to glycosaminoglycans (GAGs) on the apical surface of bovine aortic endothelial cells demonstrated a similar ROS production profile. These data establish H2O2 as the dominant (70–95%) reactive product produced by XO under clinically relevant conditions and emphasize the importance of H2O2 as a critical factor when examining the contributory roles of XO-catalyzed ROS in inflammatory processes as well as cellular signaling.
Introduction
The molybdoflavin enzyme, xanthine oxidoreductase (XOR) catalyzes the terminal two steps of purine degradation (hypoxanthine → xanthine → uric acid) in humans. XOR is transcribed as a single gene product, xanthine dehydrogenase (XDH). Substrate-derived electrons at the Mo-cofactor of XDH are transferred via Fe/S centers to a FAD moiety where NAD+ is reduced to NADH. During inflammatory conditions, post-translational modification by oxidation of critical cysteine residues or limited proteolysis converts XDH to xanthine oxidase (XO) (1, 2). The key difference between XDH and XO is the structural conformation and electrostatic microenvironment surrounding the FAD resulting in a decreased affinity for NAD+ and enhancement of affinity for O2 (3). Substrate-derived electrons at the Mo-cofactor of XO reduce O2 at the FAD-cofactor both univalently, generating superoxide (O2•−), and divalently, forming hydrogen peroxide (H2O2). However, conversion to XO is not requisite for ROS production, as XDH displays partial oxidase activity under conditions in which NAD+ levels are diminished such as the ischemic/hypoxic microenvironment encountered in vascular inflammation (4). This same inflammatory milieu leads to enhanced XO levels and thus increased XO-derived ROS formation resulting in activation of redox-dependent cell signaling reactions and alterations in vascular function. Evidence of this role for XO is exemplified by numerous studies in which XO inhibition attenuates symptoms of vascular disease including congestive heart failure, sickle cell anemia and diabetes (5–8).
Reports of XO-derived ROS production frequently address XO as the O2•−-producing form of XDH and H2O2 is produced as a secondary byproduct of spontaneous or enzymatic dismutation of O2•−. A crucial concept is often overlooked, specifically, that under relatively physiologic conditions (21% O2 and pH 7.0) XO catalyzes the reduction of O2 to H2O2 and O2•− at a ratio of 4:1 (H2O2:O2•−) or ~80% H2O2 and ~20% O2•− , whereas production of 100% O2•− requires an environment of 100% O2 at pH 10 (9). While some studies have acknowledged this characteristic of XO (10–15), it is vastly underappreciated in the literature where focus remains fixed on O2•− as the key reactive product derived from XO. In addition, a limited number of biochemical studies addressing XO-mediated H2O2 production have centered on hyperoxia and/or alkaline conditions, which are less reflective of pathophysiologic conditions under which XOR most likely exerts significant influences (9, 16–18). With renewed attention being focused on XO-derived ROS in numerous inflammatory processes, the relationship between O2 concentration and XO-catalyzed H2O2/O2•− formation is crucial for the evaluation of contributory roles of XO and subsequent design of pharmacological approaches for treatment. In toto, these issues affirm the need for the examination of XO-derived ROS under clinically relevant conditions as performed herein.
Materials and Methods
Materials
Xanthine, allopurinol, diphenyleneiodonium chloride (DPI), Chelex resin, catalase and uric acid were from Sigma (St. Louis, MO). Medium 199 and fetal bovine serum (FBS) were from Invitrogen (Carlsbad, CA). Superoxide dismutase (CuZnSOD) was from OXIS International Inc. (Portland, OR).
Buffer Treatment
Buffers for all experiments were prepared from MilliQ H2O and treated with Chelex resin to remove adventitious metals and thus minimize loss of ROS by metal-catalyzed reactions.
XO Activity
Enzyme was purified from fresh bovine cream by the method of Rajagopalan and stored in ammonium sulfate at 4°C until immediately before use (19). Enzymatic activity was determined either spectrophotometrically by the rate of uric acid formation monitored at 292 nm in 50 mM potassium phosphate (KPi), pH 7.4 (ε = 11 mM−1 cm−1) or electrochemically via reverse phase HPLC analysis of uric acid production (ESA CoulArray System, Chelmsford, MA), (1 Unit = 1 µmole urate/min) as previously (20). XDH activity was distinguished from XO activity by incubation with NAD+ as previously described (21). Formation of O2•− was assessed by the SOD-inhibitable reduction of cytochrome c (550 nm) (9).
Univalent/Divalent Flux
Univalent flux was determined as previously reported (9). Briefly, under saturating xanthine concentrations, the total electron flux through the enzyme to O2 was calculated as the rate of uric acid formation. Under saturating cytochrome c concentrations, the rate of SOD-inhibitable cytochrome c reduction represents a measure of electron flux via the univalent reduction of O2 to O2•−. Dividing the cytochrome c reduction rate (1 e−) by the uric acid formation rate (2 e−) gives the % univalent flux (cyto c / 2(uric acid) ×100). As O2 is the sole oxidizing substrate in the system, the divalent flux is derived by subtracting % univalent flux from 100.
XO Binding to GAGs
Xanthine oxidase was bound to heparin Sepharose 6B (HS6B) as previously (20). Briefly, XO (2 mg/ml) was added to a fixed amount of gel (0.05 g dry weight) and the mixture gently stirred in 5 mM KPi, pH 7.4 (2 ml final volume) at 25°C for 30 min. The suspension was centrifuged at 10,000 × g for 5 min, washed and the pellet resuspended in 5 mM KPi, pH 7.4. A quantity of HS6B-XO, equaling 5 mU/ml of XO activity, was added to PBS pH 7.4 in a 3 ml cuvette containing a small stir bar. Continuous gentle stirring was maintained with a Helma electronic stirrer placed inside the spectrophotometer cavity.
Oxygen Tension Experiments
Experiments at specific oxygen tensions were performed in a table-top glove box (Coy Instruments, Grass Lake, MI, USA) purged with N2. All buffers were equilibrated >18 h before use. Glove box atmospheric O2 conditions were followed with an O2 monitor (Maxtec, Salt Lake City, UT) and O2 concentrations verified with a clinical blood gas analyzer. Spectrophotometric determinations were carried out in gas tight cuvettes. Real time concentrations of molecular O2 were determined polarographically using an Apollo 4000 Free Radical Analyzer (World Precision Instruments, Sarasota, FL, USA). Experiments were performed at standard temperature (25°C) and pressure (1 Atm).
Cellular Studies
Bovine aortic endothelial cells (BAEC) were isolated as previously (22). Primary cell culture, routine passage and experimental manipulations were all conducted in the absence of proteases. Cells were propagated by sub-culturing (1:4 ratios) in Medium 199 containing 5% FBS and thymidine (10 µM). Cells were utilized between passages 4 and 8 and were monitored visually for typical cobblestone morphology indicative of endothelial cells and by staining for von Willebrand factor expression. For O2 consumption studies, confluent BAEC were exposed to XO (5 mU/ml) for 20 min at 25°C, harvested by mechanical dissociation, washed thoroughly (3 times with ice-cold PBS, pH 7.4), resuspended as a single-cell suspension (2 × 106 cells /ml) and placed on ice (for less than 1 h) until warmed to 25°C immediately before evaluation. This method minimizes cellular internalization of the enzyme as we have previously demonstrated (23). Cell viability was 93% following 1 h on ice as determined by Trypan blue dye exclusion. Oxygen consumption studies were performed under various O2 tensions, as above, in the presence and absence of 50 U/ml CAT and/or SOD.
Statistics
Data were analyzed using one way analysis of variance followed by Tukey’s range test for multiple pair-wise comparisons. Significance was determined as p < 0.05.
Results
Univalent/Divalent Flux
At 21% O2, oxidation of xanthine (100 µM) to uric acid by XO (5 mU/ml) resulted in 28.1 ± 1.4% univalent flux (O2•− formation) in accordance with our previous reports, Table 1 (20, 24). Between 21 and 5% O2, univalent flux remained relatively constant at ~70 %. As O2 concentration was lowered below 5%, there was an O2-dependent decrease in univalent flux so that O2•− formation accounted for only 10% of electron flow through the enzyme at 1% O2. Likewise, XO-dependent divalent reduction of O2 to H2O2 increased from 72 % (21% O2) to 90% (1% O2). As O2 tensions dropped below the Km for O2 (46 µM) an O2-dependent decrease in the total electron flux (as determined by the formation of uric acid) through the enzyme was observed (1% = 13 µmoles/min, 2.5% = 18 µmoles/min and 5% = 2.3 µmoles/min) (1, 2.5 and 5% O2 = ~13, 29 and 59 µM O2, respectively) (25). This was reflected by a decrease in the overall rates of both uric acid formation and cytochrome c reduction. Control experiments conducted in the presence of catalase (CAT) demonstrated no H2O2-mediated reoxidation of cytochrome c during the initial 60 s of the reaction (the time frame for all univalent flux studies herein) that could account for the observed reduction in O2•− formation. Additional control experiments demonstrated that XO preparations were not contaminated with SOD as determined by both western-blot and activity assays. When O2 tension was elevated to 95%, the percent univalent flux increased to 47.2 ± 2.3 (data not shown).
Table 1. Oxygen dependence of univalent vs. divalent flux for XO.
[O2] % | O2•− % Univalent Flux |
H2O2 % Divalent Flux |
---|---|---|
1 | 10.4 ± 0.6 | 90 |
2.5 | 14.3 ± 0.9 | 86 |
5 | 24.6 ± 2.3 | 76 |
10 | 28.5 ± 0.7 | 71 |
15 | 27.8 ± 0.5 | 72 |
21 | 28.1 ± 1.4 | 72 |
Values for univalent flux were calculated by monitoring the SOD-inhibitible reduction of cytochrome c (550 nm) as described in the methods. Values for divalent flux were derived by subtracting the percent univalent flux from 100.
Oxygen Consumption
Initiation of XO turnover by addition of xanthine (100 µM), at 1% O2, resulted in a rapid rate of O2 consumption, Fig 1A. Increasing the O2 concentration from 1–5% resulted in an O2-dependent increase in the rate of O2 consumption similar to the effects observed for univalent flux studies. At 1% O2, the addition of CAT (50 U/ml) after 4.7 µM of O2 was consumed, produced an immediate and pronounced evolution of O2 (2.1 µM) from Reaction 1, Fig. 1B. Similar experiments carried out at different O2 concentrations revealed an O2-dependent diminution of CAT-induced O2 evolution between 1–5% O2 with no further decrease in O2 evolved above 5% O2, Fig. 1C and 1D. It is important to note that the quantity of H2O2 consumed by CAT is represented by 2 × O2 evolved from Reaction 1. For example, at 1% O2, CAT addition resulted in 2.1 µM O2 evolution representing the enzymatic catalysis of 4.2 µM H2O2 and thus 89% of the O2 consumed was due to H2O2 formation. Similar calculations for % H2O2 formation from O2 consumption at the various O2 tensions yielded: (89% (1% O2), 77% (2.5% O2), 72% (5% O2), 64% (10% O2), 68% (15% O2) and 65% (21% O2)).
Reaction 1 |
Reaction 2 |
Addition of SOD (50 mU/ml) during enzyme turnover did not alter the rate of O2 consumption from Reaction 2, Fig. 2A. At 1% O2, when SOD or CAT was added to the sample before xanthine, CAT significantly decreased the rate of O2 consumption while SOD did not, Fig. 2B. However, the addition of both SOD and CAT resulted in an additional decrease in the O2 consumption rate, compared to that produced by CAT alone, as diagrammed in Fig. 2C. Plotting the O2 consumption rates in the presence of (SOD + CAT) as a percentage of the CAT only rates for each O2 tension revealed an O2-dependent decrease in the SOD + CAT rates from 1–5% O2, Fig. 2D. For all O2 consumption studies, addition of boiled CAT or SOD did not affect O2 evolution or rates of O2 consumption, not shown.
Effects of pH
The effect of pH (5.5–7.4) on the relative proportions of O2•− and H2O2 formation by XO were determined under various O2 concentrations (1–21%) at saturating xanthine concentrations (100 µM). There was no effect of pH on univalent/divalent flux at any of the O2 concentrations examined, data not shown.
XO-Immobilization
At 21% O2, immobilization of XO by binding to heparin-Sepharose 6B (HS6B-XO) reduced the rates of urate formation and cytochrome c reduction as we reported previously (20), Table 2 and online supplement. In addition to an immobilization-induced reduction of total electron flow through the enzyme, the relative proportion of O2•− and H2O2 was also altered, reducing univalent electron transfer to O2 by 30% compared to XO in solution. This immobilization-induced reduction in univalent flux was consistent for all O2 tensions examined, such that at 1% O2, univalent flux was only 6.9 % for bound XO compared to 10.4% univalent flux for free XO.
Table 2. Oxygen dependence of univalent vs. divalent flux for GAG-imobilized XO.
[O2] % | % O2•− | % H2O2 | ||
---|---|---|---|---|
free | bound | free | bound | |
1 | 10.4 ± 0.6 | 6.9 ± 1.2 | 90 | 93 |
5 | 24.6 ± 2.3 | 17.4 ± 4.2 | 76 | 83 |
10 | 28.5 ± 0.7 | 18.9 ± 2.1 | 71 | 81 |
21 | 28.1 ± 1.4 | 19.8 ± 1.1 | 72 | 80 |
Values for univalent flux were calculated by monitoring the SOD-inhibitible reduction of cytochrome c (550 nm) as described in the methods. Values for divalent flux were derived by subtracting the percent univalent flux from 100.
Endothelial cell-bound XO
Xanthine oxidase was bound to extracellular GAGs on the apical surface of BAEC as described in the methods. Cellular O2 consumption studies were performed at various O2 tensions (1–21%) in which CAT (200 U/ml), SOD (200 U/ml) or both were present before addition of xanthine. The effect of the presence of the antioxidants on the rate of XO-dependent O2 consumption was determined and plotted as percent decrease when compared to control rates (no SOD or CAT) at each O2 tension, Fig. 3. The presence of CAT significantly decreased the rate of O2 consumption at all O2 tensions resulting in a 27% decrease at 1% O2 while SOD produced small, but significant, decreases (>5%) at O2 levels above 2.5%. The presence of both SOD and CAT did not significantly alter rates of O2 consumption compared to samples containing only CAT. Rates of O2 consumption in the absence of xanthine were determined and subtracted from all values reported. When XO-treated cells were washed and then exposed to trypsin (0.25%) for 3 min at 37°C to remove/inactivate GAG-associated enzyme, no O2 consumption was observed upon addition of xanthine demonstrating that ROS formation was from cell-associated XO. Furthermore, treatment with the XO-specific inhibitor, Febuxostat (25 µM), before addition of xanthine, abolished XO-dependent O2 consumption, not shown.
Discussion
Studies on reactive species derived from XO have confirmed the biological production of O2•− (26). However, under normoxic conditions at neutral pH, XO produces significantly greater quantities of H2O2 (9). Perhaps of more significance, is that under the lower O2 tensions and pH encountered during inflammation or ischemia, H2O2 accounts for 90–95% of XO-derived ROS formation, Table 1 and Table 2. These data confirm an O2 dependence for ROS formation where lower O2 concentrations lead to even greater H2O2 formation by XO. Conceptually, this can be illustrated by consideration of the overall oxidation/reduction state of the enzyme, Fig. 4. This scheme, albeit a very simplified representation of a complex series of electronic interactions between cofactors, summarizes the concept that a more reduced XO favors H2O2 production while a more oxidized XO favors O2•− formation. This effect of the redox state of XO on H2O2 vs. O2•− production has been previous reported with purified enzyme at pH 8.5 and confirms that high concentrations of xanthine and low O2 tensions result in greater H2O2 production while low concentrations of xanthine and high O2 tensions result in greater O2•− formation (18, 27–29). This is critical to note as hypoxia/inflammation leads to lower O2 tensions, increased XO expression as well as increased hypoxanthine/xanthine levels from ATP catabolism and thus sets the stage for enhance vascular H2O2 production. Therefore, recognizing that both reducing substrate concentration and O2 tension are the key factors determining the identity XO-mediated ROS formation, we examined the effects of O2 tension in the presence of a saturating xanthine concentration (100 µM). We chose this xanthine level as it reflects the concentrations encountered in vivo under ischemic/hypoxic conditions where ATP breakdown results in elevation of hypoxanthine/xanthine levels from ~2 µM to 50–100 µM, well above its Km (6.5 µM) (20). In aggregate, our studies were designed to confirm and expand the observations of previous studies under clinically-relevant conditions and to refocus attention on XO-derived H2O2.
Electron flux studies utilize uric acid formation and cytochrome c reduction to determine univalent flux; however, they do not directly measure divalent flux and thus it is a derived value. In a simple system in which O2 is the sole electron acceptor, this is a valid calculation; however, an alternative approach which measures XO-derived H2O2 formation would confirm conclusions based on this derivation. Oxygen consumption was chosen to examine XO-dependent H2O2 formation in the presence and absence of CAT and SOD, the enzymes most often used to substantiate contributions of H2O2 and O2•− in biological systems, Fig. 1. This avoids possible direct interactions with XOR, ROS specificity issues and the potential of redox cycling which limit the specificity and sensitivity of several dye-based H2O2 assays (30). At 1% O2, CAT addition resulted in significant evolution of O2, indicating that 89% of the O2 consumed by XO was reduced to H2O2. Values obtained at other O2 tensions were also similar to, yet slightly lower than, the divalent fluxes listed in Table 1 supporting the validity of this approach. Lower yields for the O2 evolution experiments may be due to the extended time (~2 min) of enzyme turnover and thus potential loss of H2O2 before the addition of CAT and/or subtle variations in temperature and barometric pressure.
Since CAT addition experiments confirmed the proportion of H2O2 formed during XO-catalyzed O2 consumption, then the remainder of O2 consumption should be attributable to O2•− formation. However, at 1% O2, the presence of SOD before or after (Fig. 2) the addition of xanthine resulted in neither O2 evolution nor alteration of the O2 consumption rate. It is hypothesized that loss of O2•− from spontaneous dismutation (~2 × 105 M−1 s−1), reaction with protein in the sample and degree of assay sensitivity all contributed to the absence of observable effects. To further address this issue, experiments were performed in which both SOD and CAT were present before initiation of enzyme turnover. At all O2 tensions, addition of SOD + CAT before xanthine decreased the rate of O2 consumption compared to samples containing only CAT, Fig. 2C and 2D. It is assumed that both O2 evolution and the formation of additional CAT substrate (H2O2) by SOD (Reaction 2) served to augment total O2 evolution. The CAT + SOD-induced decreases in O2 consumption rates were not O2-dependent above 5% O2 (Fig. 2D) which is consistent with data from univalent flux studies showing no significant increase in O2•− formation from 5–21% O2. This result is also consistent with the argument that as O2 levels exceed the Km of O2 with the FAD (46 µM), a constant rate of O2•− formation would ensue where the presence of SOD offers no additional contribution to O2 evolution and subsequent reduction in the rate of O2 consumption in this O2 concentration range (46–235 µM or 5–21%).
Inflammation is often characterized by both hypoxia and lowered pH; thus, it is important to consider the effects of H+ ion concentration on ROS production by XO. The oxidation of xanthine at the Mo-cofactor is base-catalyzed and thus sensitive to changes of pH in the physiological range as well as substrate concentration (27). However, under saturating xanthine concentrations, the relative proportion of H2O2 to O2•− at each O2 tension examined was not altered by pH (5.5–7.4).
During inflammatory conditions XDH is released into the circulation, rapidly converted to XO and avidly binds (Kd = 6 nM) to negatively charged glycosaminoglycans (GAGs) on the surface of vascular endothelial cells (24, 31–33). This sequestration of XO by GAGs substantially amplifies local enzyme concentration, diminishes its rotational and translational mobility, thus, altering kinetic properties and conferring resistance to both product-induced and pharmacological inhibition (20, 24). GAG association of XO decreases substrate binding affinity and thus increases the Km for xanthine (6.5 µM free vs. 21.2 µM bound) and Ki for oxypurinol (85 nM free vs. 451 nM bound) when compared to XO in solution (24, 34). These characteristics indicate that XO bound to endothelial cell GAGs could serve as a long-lived source of ROS in this microenvironment. It is in this setting that XO-generated ROS can critically impact vessel function, emphasizing the need to more clearly define the effects of O2 tension on ROS production by GAG-bound XO. Our previous studies demonstrate immobilization of XO on heparin-Sepharose reduces univalent flux by 30% in room air (20). At every O2 concentration examined, GAG immobilization of XO produced a similar ~30% reduction in univalent flux, so that at 1% O2, 93% of the ROS formed was H2O2. These data suggest XO-derived ROS production is almost exclusively H2O2 when XO is bound to endothelial GAGs in a hypoxic vascular milieu. To test this hypothesis in a cellular model, BAEC were exposed to purified XO and XO-dependent O2 consumption was monitored over time in the presence of SOD, CAT or CAT + SOD, Fig. 3. The presence of SOD slightly altered O2 consumption rates only when O2 tensions exceeded 5%. In contrast, CAT significantly decreased rates of O2 consumption as XO-produced H2O2 was converted to H2O and O2. These CAT-dependent decrements in O2 consumption rates were seen at all O2 tensions, with the greatest effects observed below 5% where H2O2 production would be expected to account for a preponderance of total ROS formation. The presence of both CAT and SOD produced O2 consumption rates that were not statistically different from rates produced by samples containing only CAT. While differences between the CAT + SOD and CAT only values did not demonstrate statistical significance, the individual mean values for CAT + SOD from 5–21% O2 were all greater than the corresponding CAT only values, possibly suggesting contributions from SOD near the limit of detection. Combined, these data demonstrate that quantification and characterization of ROS from these cellular studies is problematic due to loss of both H2O2 and O2•− before reaction with CAT and SOD from many mechanisms including reactions with cellular constituents such as GSH. However, they do reveal similar trends to those observed in the biochemical studies and qualitatively demonstrate that H2O2 is the major ROS product of XO, especially at O2 tensions relevant to vascular pathology.
Over the past several years, there is renewed interest in the role of XO in vascular inflammation as the number of studies demonstrating salutary effects of XO inhibition accumulate. In order to successfully evaluate the contribution of XO in these and future studies, it is crucial to understand the identity and relative proportions of the ROS produced by this complex enzyme under conditions reflective of the microenvironment in which they are formed. Herein, we revisit the underappreciated detail that H2O2 is the major (~75%) ROS produced by XO under normal aerobic conditions and expand this observation to demonstrate that under pathophysiologic conditions XO-derived H2O2 formation approaches 95%. These results affirm the need to more critically evaluate the role of H2O2 in studies where XO-derived ROS have been proposed to play a contributory role. For example, many of the vessel studies in which XO-derived O2•− reduces NO-mediated vasodilatation were conducted using 95% O2. This O2 tension is significantly higher than O2 levels experienced in vivo, and also serves to greatly enhance XO-derived O2•− formation and possibly lead to misconceptions regarding the role XO in this model. Furthermore, assigning a causative role for XO-derived O2•− based upon the beneficial actions of allopurinol administration, in the absence of controls for XO-derived H2O2, may result in neglecting pivotal signaling events mediated by H2O2, a molecule with an expanding number of targets in various cell signaling pathways (35–37).
Combined, the results from this report refocus attention on previous and commonly overlooked studies reporting H2O2 as the major ROS product of XO under normoxia. Furthermore, these data demonstrate that under pathophysiologic conditions XO-derived H2O2 formation approaches 95% and thus underscores the danger of failing to appreciate this attribute when investigating contributory roles for XO in pathology.
Acknowledgements
This study was supported by a University of Pittsburgh, Department of Anesthesiology Seed Grant (EEK). The authors would like to thank Dr. Joe S. Moritz, Ph.D. and Dr. Keith Inskeep, Ph.D., Division of Animal and Veterinary Science, West Virginia University, Morgantown, WV for both fresh cream and chicken livers used in enzyme purification.
Abbreviations
- BAEC
bovine aortic endothelial cells
- CAT
catalase
- GAGs
glycosaminoglycans
- ROS
reactive oxygen species
- SOD
superoxide dismutase
- XDH
xanthine dehydrogenase
- XO
xanthine oxidase
- XOR
xanthine oxidoreductase
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Amaya Y, Yamazaki K, Sato M, Noda K, Nishino T. Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J.Biol.Chem. 1990;265:14170–14175. [PubMed] [Google Scholar]
- 2.Waud WR, Rajagopalan KV. The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O) Arch.Biochem.Biophys. 1976;172:365–379. doi: 10.1016/0003-9861(76)90088-6. [DOI] [PubMed] [Google Scholar]
- 3.Enroth C, Eger BT, Okamoto K, Nishino T, Nishino T, Pai EF. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion. Proc.Natl.Acad.Sci.USA. 2000;97:10723–10728. doi: 10.1073/pnas.97.20.10723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Harris CM, Massey V. The Oxidative Half-reaction of Xanthine Dehydrogenase with NAD; Reaction Kinetics and Steady-state Mechanism. J.Biol.Chem. 1997;272:28335–28341. doi: 10.1074/jbc.272.45.28335. [DOI] [PubMed] [Google Scholar]
- 5.Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000;35:746–751. doi: 10.1161/01.hyp.35.3.746. [DOI] [PubMed] [Google Scholar]
- 6.Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes. 2002;51:1118–1124. doi: 10.2337/diabetes.51.4.1118. [DOI] [PubMed] [Google Scholar]
- 7.Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106:221–226. doi: 10.1161/01.cir.0000022140.61460.1d. [DOI] [PubMed] [Google Scholar]
- 8.Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, Freeman BA. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc.Natl.Acad.Sci.USA. 2001;98:15215–15220. doi: 10.1073/pnas.221292098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fridovich I. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J.Biol.Chem. 1970;245:4053–4057. [PubMed] [Google Scholar]
- 10.McCutchan HJ, Schwappach JR, Enquist EG, Walden DL, Terada LS, Reiss OK, Leff JA, Repine JE. Xanthine oxidase-derived H2O2 contributes to reperfusion injury of ischemic skeletal muscle. Am.J.Physiol. 1990;258:H1415–H1419. doi: 10.1152/ajpheart.1990.258.5.H1415. [DOI] [PubMed] [Google Scholar]
- 11.Brown JM, Terada LS, Grosso MA, Whitmann GJ, Velasco SE, Patt A, Harken AH, Repine JE. Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J.Clin.Invest. 1988;81:1297–1301. doi: 10.1172/JCI113448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Siems W, Schmidt H, Muller M, Henke W, Gerber G. H2O2 formation during nucleotide degradation in the hypoxic rat liver: a quantitative approach. Free Radic.Res.Commun. 1986;1:289–295. doi: 10.3109/10715768609080967. [DOI] [PubMed] [Google Scholar]
- 13.Patt A, Harken AH, Burton LK, Rodell TC, Piermattei D, Schorr WJ, Parker NB, Berger EM, Horesh IR, Terada LS. Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains. J.Clin.Invest. 1988;81:1556–1562. doi: 10.1172/JCI113488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Fatokun AA, Stone TW, Smith RA. Hydrogen peroxide mediates damage by xanthine and xanthine oxidase in cerebellar granule neuronal cultures. Neurosci.Lett. 2007;416:34–38. doi: 10.1016/j.neulet.2007.01.078. [DOI] [PubMed] [Google Scholar]
- 15.Lee H, Carlson JD, McMahon KK, Moyer TP, Fischer AG. Xanthine oxidase: a source of hydrogen peroxide in bovine thyroid glands. Life Sci. 1977;20:453–458. doi: 10.1016/0024-3205(77)90387-3. [DOI] [PubMed] [Google Scholar]
- 16.Lacy F, Gough DA, Schmid-Schonbein GW. Role of xanthine oxidase in hydrogen peroxide production. Free Radic.Biol.Med. 1998;25:720–727. doi: 10.1016/s0891-5849(98)00154-3. [DOI] [PubMed] [Google Scholar]
- 17.Kellogg EW, III, Fridovich I. Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J.Biol.Chem. 1975;250:8812–8817. [PubMed] [Google Scholar]
- 18.Porras AG, Olson JS, Palmer G. The reaction of reduced xanthine oxidase with oxygen. Kinetics of peroxide and superoxide formation. J.Biol.Chem. 1981;256:9006–9103. [PubMed] [Google Scholar]
- 19.Waud WR, Brady FO, Wiley RD, Rajagopalan KV. A new purification procedure for bovine milk xanthine oxidase: effect of proteolysis on the subunit structure. Arch. Biochem. Biophys. 1975;169:695–701. doi: 10.1016/0003-9861(75)90214-3. [DOI] [PubMed] [Google Scholar]
- 20.Kelley EE, Trostchansky A, Rubbo H, Freeman BA, Radi R, Tarpey MM. Binding of Xanthine Oxidase to Glycosaminoglycans Limits Inhibition by Oxypurinol. J.Biol.Chem. 2004;279:37231–37234. doi: 10.1074/jbc.M402077200. [DOI] [PubMed] [Google Scholar]
- 21.Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc.Natl.Acad.Sci.USA. 1998;95:4754–4759. doi: 10.1073/pnas.95.8.4754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kelley EE, Hock T, Khoo NKH, Richardson GR, Johnson KK, Powell PC, Giles GI, Agarwal A, Lancaster JR, Jr, Tarpey MM. Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radic.Biol.Med. 2006;40:952–959. doi: 10.1016/j.freeradbiomed.2005.11.008. [DOI] [PubMed] [Google Scholar]
- 23.Kelley EE, Batthyany CI, Hundley NJ, Woodcock SR, Bonacci G, Del Rio JM, Schopfer FJ, Lancaster JR, Jr, Freeman BA, Tarpey MM. Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase. J.Biol.Chem. 2008;283:36176–36184. doi: 10.1074/jbc.M802402200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Radi R, Rubbo H, Bush K, Freeman BA. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes. Arch.Biochem.Biophys. 1997;339:125–135. doi: 10.1006/abbi.1996.9844. [DOI] [PubMed] [Google Scholar]
- 25.Saito T, Nishino T. Differences in redox and kinetic properties between NAD-dependent and O2-dependent types of rat liver xanthine dehydrogenase. J.Biol.Chem. 1989;264:10015–10022. [PubMed] [Google Scholar]
- 26.McCord JM, Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J.Biol.Chem. 1968;243:5753–5760. [PubMed] [Google Scholar]
- 27.Hille R, Massey V. Studies on the oxidative half-reaction of xanthine oxidase. J.Biol.Chem. 1981;256:9090–9095. [PubMed] [Google Scholar]
- 28.Olson JS, Ballow DP, Palmer G, Massey V. The reaction of xanthine oxidase with molecular oxygen. J.Biol.Chem. 1974;249:4350–4362. [PubMed] [Google Scholar]
- 29.Olson JS, Ballou DP, Palmer G, Massey V. The mechanism of action of xanthine oxidase. J.Biol.Chem. 1974;249:4363–4382. [PubMed] [Google Scholar]
- 30.Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ.Res. 2001;89:224–236. doi: 10.1161/hh1501.094365. [DOI] [PubMed] [Google Scholar]
- 31.Adachi T, Fukushima T, Usami Y, Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem.J. 1993;289:523–527. doi: 10.1042/bj2890523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Fukushima T, Adachi T, Hirano K. The heparin-binding site of human xanthine oxidase. Biological & Pharmaceutical Bulletin. 1995;18:156–158. doi: 10.1248/bpb.18.156. [DOI] [PubMed] [Google Scholar]
- 33.Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, Freeman BA. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J.Biol.Chem. 1999;274:4985–4994. doi: 10.1074/jbc.274.8.4985. [DOI] [PubMed] [Google Scholar]
- 34.Camejo G, Olsson U, Hurt-Camejo E, Baharamian N, Bondjers G. The extracellular matrix on atherogenesis and diabetes-associated vascular disease. Atheroscler.Suppl. 2002;3:3–9. doi: 10.1016/s1567-5688(01)00005-8. [DOI] [PubMed] [Google Scholar]
- 35.Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr.Opin.Cell Biol. 2005;17:183–189. doi: 10.1016/j.ceb.2005.02.004. [DOI] [PubMed] [Google Scholar]
- 36.Forman HJ, Torres M. Reactive Oxygen Species and Cell Signaling: Respiratory Burst in Macrophage Signaling. Am.J.Respir.Crit.Care Med. 2002;166:4S–8S. doi: 10.1164/rccm.2206007. [DOI] [PubMed] [Google Scholar]
- 37.Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc.Res. 2005;68:26–36. doi: 10.1016/j.cardiores.2005.06.021. [DOI] [PubMed] [Google Scholar]